Home Small Caps

Small Caps

Random

AngioDynamics, Inc. (NASDAQ:ANGO) Files An 8-K

ME Staff - October 10, 2016

What Are The Effects Of The Allegheny Technologies Incorporated (NYSE:ATI) Plant Shutdown?

Logitech International SA (USA)(NASDAQ:LOGI) Launches Revised Gaming Keyboard

Supervalu Inc. (NYSE:SVU) Moves Closer To Separating Save-A-Lot

Here’s What The Novartis AG (ADR) (NYSE:NVS) Deal Means For Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

Is Fairmount Santrol Holdings Inc (NYSE:FMSA) Out Of The Woods?

Andy Parker - July 29, 2016

Sanchez Production Partners LP (NYSEMKT:SPP) Increasingly Growing Its Shale Drilling Stake...

Andy Parker - February 16, 2017

LendingClub Corp (NYSE:LC) Faces Class Action Lawsuit

Andy Parker - July 6, 2016

ADTRAN, Inc. (NASDAQ:ADTN) To Host 8th Semi-Annual BBSS Event At ADTRAN’s...

Adam Russell - April 22, 2016

BP plc (ADR) (NYSE:BP) Acquires Assets For Gas Production From Clean...

Andy Parker - March 2, 2017

SunPower Corporation (NASDAQ:SPWR) Extends Partnership With Solar Power Evangelist

Andy Parker - November 8, 2016

SunPower Corporation (NASDAQ:SPWR) Bets On Residential And Utility Solar To Get...

Andy Parker - February 24, 2017

Amarin Corporation plc (ADR) (NASDAQ:AMRN) Renders Smaller Vascepa Capsule

Adam Russell - October 26, 2016

What Does Ziopharm Oncology Inc. (NASDAQ:ZIOP) Genetic Editing Process Entail?

Andy Parker - February 25, 2016

Desjardins Maintains Buy Rating For CAE (NYSE:CAE)

Adam Russell - February 11, 2016

12 3...69 Page 1 of 69

EDITOR PICKS

Xenon Pharmaceuticals (XENE) Just Took A Hit: Here’s Why And What’s...

June 28, 2017

Here’s Why These Two Biotechnology Companies Took A Hit On Monday:...

June 27, 2017

Here’s What Just Happened With Portola Pharmaceuticals Inc (NASDAQ:PTLA) and bluebird...

June 26, 2017

Vistagen Therapeutics Is A $17M Company With a Potentially $2.8B Drug

June 6, 2017

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.